CD38 and periodontitis: Our and other studies support that the inhibition of CD38 by 78c could serve as an adjunctive therapy for aging associated diseases, such as aging-associated periodontitis, to inhibit periodontal inflammation, attenuate osteoclastogenesis and alveolar bone resorption, alleviate oxidative stress, and prolong the health span of human beings.